Close Menu

Blogger Thomas Mailund muses about what he would do if $1,000 genomes were readily available in the next year. Since his focus is on finding disease associations, he says the big difference would come from the ability to detect more variants. "With SNP chips and tagging SNPs, we are looking for high-frequent variants with modest effect," he writes. "With full sequencing, we will be able to look for low frequency variants as well."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.